6JS Stock Chart & Stats
€4.62
-€0.02(-0.28%)
At close: 4:00 PM EST
€4.62
-€0.02(-0.28%)
Day’s Range― - ―
52-Week Range€3.88 - €6.19
Previous CloseN/A
Volume0.00
Average Volume (3M)215.00
Market Cap
€162.37M
Enterprise Value€639.19
Total Cash (Recent Filing)€9.05M
Total Debt (Recent Filing)€446.18M
Price to Earnings (P/E)4.3
Beta0.30
Next Earnings
Aug 05, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.06
Shares Outstanding40,598,980
10 Day Avg. Volume150
30 Day Avg. Volume215
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.74
Price to Sales (P/S)2.71
P/FCF Ratio-4.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.37Price Target Upside-5.40% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.82
Revenue Forecast (FY)€80.37M
Bulls Say, Bears Say
Bulls Say
Credit ValuationCredit positives were with Revolut, where TPVG sold a small amount in its recent secondary and another is now being discussed at a higher valuation.
Stock IssuanceTPVG is currently issuing stock through its DRIP, which preserves cash and builds overall NAV.
Venture Capital ActivityStable NAV and upbeat management on venture capital activity were welcome developments.
Bears Say
Earnings PressureEarnings sees a bit more pressure absent significant success in legacy rotation.
Incentive FeeThe incentive fee and 2026 Notes are set to be sharp headwinds into next year.
Net Operating IncomeTPVG reported NOI of $0.27 below consensus $0.30 estimate.
TriplePoint Venture Growth News
6JS FAQ
What was TriplePoint Venture Growth’s price range in the past 12 months?
TriplePoint Venture Growth lowest stock price was €3.88 and its highest was €6.19 in the past 12 months.
What is TriplePoint Venture Growth’s market cap?
TriplePoint Venture Growth’s market cap is €162.37M.
When is TriplePoint Venture Growth’s upcoming earnings report date?
TriplePoint Venture Growth’s upcoming earnings report date is Aug 05, 2026 which is in 14 days.
How were TriplePoint Venture Growth’s earnings last quarter?
TriplePoint Venture Growth released its earnings results on May 06, 2026. The company reported €0.196 earnings per share for the quarter, missing the consensus estimate of €0.208 by -€0.012.
Is TriplePoint Venture Growth overvalued?
According to Wall Street analysts TriplePoint Venture Growth’s price is currently Overvalued.
Does TriplePoint Venture Growth pay dividends?
TriplePoint Venture Growth does not currently pay dividends.
What is TriplePoint Venture Growth’s EPS estimate?
TriplePoint Venture Growth’s EPS estimate is 0.21.
How many shares outstanding does TriplePoint Venture Growth have?
TriplePoint Venture Growth has 40,598,980 shares outstanding.
What happened to TriplePoint Venture Growth’s price movement after its last earnings report?
TriplePoint Venture Growth reported an EPS of €0.196 in its last earnings report, missing expectations of €0.208. Following the earnings report the stock price went up 3.162%.
Which hedge fund is a major shareholder of TriplePoint Venture Growth?
Currently, no hedge funds are holding shares in DE:6JS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TriplePoint Venture Growth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€4.37 (-5.40% Downside)
€4.37 (-5.40% Downside)
Blogger Sentiment
Neutral
DE:6JS Sentiment 50%
Sector Average 62%
Sector Average 62%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.00%
12-Months-Change
Fundamentals
Return on Equity
19.58%
Trailing 12-Months
Asset Growth
9.83%
Trailing 12-Months
Company Description
TriplePoint Venture Growth
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
6JS Stock 12 Month Forecast
Average Price Target
€4.37
▼(-5.40% Downside)
Technical Analysis
―
Pennantpark Investment
―
Stellus Capital
―
Trinity Capital
―
Chicago Atlantic BDC
―










